UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Determining which travel rewards credit card is best can enhance your travel experiences. Explore your options for the best fit.
23,300 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
AI disruption fears loom over software stocks. This article explains why Unity Software is likely to endure and even ...
Uber stock jumps after AI chatter linked to Nvidia sparks a rally as the company details a 2027 robotaxi rollout and ...
A private AI-focused XR company invites retail investors to participate in a sub-$1 pre-IPO round, offering bonus sha...
Warren Buffett built wealth by buying durable businesses at fair prices. In this guide, we explore a Buffett-inspired...
As the AI rally fans the markets, the boom looks like dot-com. Yet Bitcoin bulls point to a tangible edge—scarcity an...
Apple reveals a staggering pay gap in its 2025 proxy, with CEO compensation at roughly $74 million vs. a median emplo...
A potential 18-day walkout by 45,000 Samsung memory workers could disrupt DRAM and high-bandwidth memory supply, send...
Ralph Lauren faces a pivotal year in 2026. This article breaks down the brand's strategic moves, potential growth dri...
A North American software company that pays users for scrolling has surged to the top of Deloitte’s fastest-growing l...
A high-stakes exit valued at about $5.5 million and a difficult first quarter have investors re-evaluating risk in bi...
Oracle delivered a dramatic rise in May as it pivots toward AI cloud infrastructure. This article breaks down the dri...